A detailed history of Strategic Wealth Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Wealth Investment Group, LLC holds 50,917 shares of ABBV stock, worth $9.17 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
50,917
Previous 37,832 34.59%
Holding current value
$9.17 Million
Previous $6.49 Million 54.98%
% of portfolio
1.15%
Previous 0.85%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $2.14 Million - $2.61 Million
13,085 Added 34.59%
50,917 $10.1 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $5.07 Million - $5.92 Million
32,735 Added 642.24%
37,832 $6.49 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $250,707 - $282,355
1,822 Added 55.63%
5,097 $789,000
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $212,408 - $245,893
-1,590 Reduced 32.68%
3,275 $488,000
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $166,035 - $206,619
1,253 Added 34.69%
4,865 $655,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $470,271 - $541,588
3,252 Added 903.33%
3,612 $575,000
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $443,085 - $510,278
-3,064 Reduced 89.49%
360 $57,000
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $5,255 - $6,303
38 Added 1.12%
3,424 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $55,562 - $63,727
414 Added 13.93%
3,386 $454,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $91,517 - $116,348
-665 Reduced 18.28%
2,972 $455,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $923 - $1,146
7 Added 0.19%
3,637 $590,000
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $12,139 - $15,360
113 Added 3.21%
3,630 $492,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $638 - $724
6 Added 0.17%
3,517 $378,000
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $11,362 - $12,658
108 Added 3.17%
3,511 $395,000
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $14,219 - $15,654
139 Added 4.26%
3,403 $368,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $39,923 - $53,900
496 Added 17.92%
3,264 $350,000
Q4 2020

Jan 15, 2021

SELL
$80.49 - $108.67 $44,913 - $60,637
-558 Reduced 16.78%
2,768 $297,000
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $16,580 - $19,460
193 Added 6.16%
3,326 $291,000
Q2 2020

Jul 13, 2020

SELL
$73.37 - $98.18 $10,345 - $13,843
-141 Reduced 4.31%
3,133 $308,000
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $8,965 - $13,592
-139 Reduced 4.07%
3,274 $249,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $246,179 - $308,023
3,413 New
3,413 $302,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Strategic Wealth Investment Group, LLC Portfolio

Follow Strategic Wealth Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Investment Group, LLC with notifications on news.